A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
IsraelRecruitingPHASE2, PHASE3
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Generalized Myasthenia Gravis
Locations
- Carolinas HealthCare System Neurosciences Institute - Neurology, Charlotte, North Carolina, United States
- Neurology Rare Disease Center, Denton, Texas, United States
- University of Virginia, Charlottesville, Virginia, United States
- UZ Gent, Ghent, Belgium
- Childrens Hospital of Eastern Ontario, Ottawa, Canada
- Fakultni nemocnice Brno, Brno, Czechia
- Fakultni nemocnice Ostrava, Ostrava, Czechia
- AP-HM- Hôpital de La Timone, Marseille, France
- Universitätsklinikum Essen, Essen, Germany
- Hadassah Medical Center- Ein Kerem, Jerusalem, Israel
- Schneider Children's Medical Center of Israel, Petah Tikvah, Israel
- Tel Aviv Sourasky Medical Center Ichilov, Tel Aviv, Israel
- Istituto G Gaslini Ospedale Pediatrico IRCCS, Genova, Italy
- Leiden University Medical Center, Leiden, Netherlands
- Uniwersyteckie Centrum Kliniczne w Gdansku, Gdansk, Poland
- Neurologia Śląska Centrum Medyczne, Katowice, Poland
- Centralny Szpital Kliniczny - Uniwersyteckie Centrum Kliniczne WUM, Warsaw, Poland
- Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain
- Hôpital Nestlé, Lausanne, Switzerland
- Oxford Children's Hospital, Oxford, United Kingdom